Unither Pharmaceuticals, founded in 1993, is a leading global player in the pharmaceutical contract development manufacturing organization (CDMO) sector, with headquarters in France. Positioned as a world leader, the company operates 8 manufacturing plants across France, the USA, Brazil, and China, along with 4 commercial offices and 1 R&D platform that enhance its expansive reach and operational capacity.
With its manufacturing prowess, Unither Pharmaceuticals specializes in innovative niche technologies, including Liquid Stick-Pack and Sterile unit-dose (Blow Fill & Seal Technology). Offering products in more than 100 countries supports an impressive annual turnover of 371 million euros.
Recently, the company secured a Growth Equity VC investment as of 01 October 2022, facilitated by key investors like GIC, Keensight Capital, and Parquest. This capital influx underscores their commitment to providing innovative, competitive, and sustainable solutions, aligning with their vision of affordable healthcare that enhances the lives of patients globally.